These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Surgical treatment of thymoma--clinical evaluation].
    Author: Ietsugu K, Shimizu J, Murakami S, Oda M, Hayashi Y, Tatsuzawa Y, Kobayashi K, Sekido N, Arano Y, Takahashi A.
    Journal: Kyobu Geka; 1993 Jan; 46(1):4-8. PubMed ID: 8418358.
    Abstract:
    Sixty-seven patients with thymoma were surgically treated during the past 19 years in our department. The 5-year, 10-year and 15-year survival rates of total cases with thymomas were 69.2%, 59.6% and 59.6%, respectively. Survival rates of thymoma with MG and without MG were not significantly different. According to clinical stages in Masaoka's classification, there were significant difference between Stage I and Stag III (p < 0.05), Stage I and Stage IV a (p < 0.01), and Stage I and Stage IV b (p < 0.01). We can conclude that complete resection of thymomas lead to better prognosis, and immunochemotherapy using cyclophosphamide, vincristine and OK-432 are effective.
    [Abstract] [Full Text] [Related] [New Search]